Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12616683 | Combination therapy for the treatment of gastrointestinal stromal tumors | 🖼🧊📄§ | 2026-05-05 | 2044-04-10 | 0 | 31 |
| 12616704 | Cannabichromene formulation for pain management | 🖼🧊📄§ | 2026-05-05 | 2041-03-31 | 0 | 31 |
| 12617835 | Chimeric autoantibody receptor (CAAR) that binds autoantibodies targeting the central nervous system in neurological autoimmune disease | 🖼🧊📄§ | 2026-05-05 | 2040-06-05 | 0 | 31 |
| 12616666 | Coenzyme Q10 formulations in the treatment and prevention of epidermolysis bullosa | 🖼🧊📄§ | 2026-05-05 | 2042-07-13 | 0 | 31 |
| 12616669 | Methods and chemical compositions for treating skin conditions by providing long lasting skin pH control for improving skin barrier function | 🖼🧊📄§ | 2026-05-05 | 2045-08-27 | 0 | 31 |
| 12616657 | Cell-targeted nanoparticles to inhibit RNA cargo | 🖼🧊📄§ | 2026-05-05 | 2041-02-26 | 0 | 31 |
| 12616747 | Stabilized beta-coronavirus antigens | 🖼🧊📄§ | 2026-05-05 | 2042-12-02 | 0 | 31 |
| 12616727 | Compositions, systems, and methods for improving health | 🖼🧊📄§ | 2026-05-05 | 2043-06-29 | 0 | 31 |
| 12616712 | Sting agonist comprising exosomes for treating neuroimmunological disorders | 🖼🧊📄§ | 2026-05-05 | 2040-09-24 | 0 | 31 |
| 12616692 | Method of achieving HIV viral remission using long-acting antiretroviral agents | 🖼🧊📄§ | 2026-05-05 | 2041-06-30 | 0 | 31 |
| 12616671 | Use of rigosertib to treat RNA virus infections | 🖼🧊📄§ | 2026-05-05 | 2041-05-28 | 0 | 31 |
| 12617813 | Glycosylated histone deacetylase inhibitors and methods of making and using the same | 🖼🧊📄§ | 2026-05-05 | 2041-12-28 | 0 | 31 |
| 12618048 | Dual CAR-T cells | 🖼🧊📄§ | 2026-05-05 | 2041-07-30 | 0 | 31 |
| 12617774 | Substituted indole compounds and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2045-05-30 | 0 | 31 |
| 12611440 | Fusion proteins and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2040-09-03 | 0 | 31 |
| 12612612 | Methods for exon skipping and gene knockout using base editors | 🖼🧊📄§ | 2026-04-28 | 2039-07-19 | 0 | 31 |
| 12612343 | PSMA binder and use thereof | 🖼🧊📄§ | 2026-04-28 | 2041-04-13 | 0 | 31 |
| 12612441 | Polypeptide and therapeutic uses thereof | 🖼🧊📄§ | 2026-04-28 | 2040-01-07 | 0 | 31 |
| 12611433 | Anaerostipes sp B2131 strain and application thereof in inflammatory bowel diseases | 🖼🧊📄§ | 2026-04-28 | 2041-01-08 | 0 | 31 |
| 12611467 | APOE gene therapy | 🖼🧊📄§ | 2026-04-28 | 2040-11-25 | 0 | 31 |
| 12611412 | Targeting the TLK1/NEK1 axis in prostate cancer | 🖼🧊📄§ | 2026-04-28 | 2043-11-15 | 0 | 31 |
| 12611457 | Bispecific antibodies specifically binding to PD1 and LAG3 | 🖼🧊📄§ | 2026-04-28 | 2042-03-07 | 0 | 31 |
| 12611430 | Therapeutic agent of peripheral blood flow disorder | 🖼🧊📄§ | 2026-04-28 | 2039-11-29 | 0 | 31 |
| 12611419 | Liposomal composition for use in a method of treating Parkinson's disease | 🖼🧊📄§ | 2026-04-28 | 2043-03-09 | 0 | 31 |
| 12611432 | Immunostimulatory bacteria for the treatment of cancer | 🖼🧊📄§ | 2026-04-28 | 2043-07-11 | 0 | 31 |
| 12611431 | Approach to sustained production and delivery of nitric oxide and S-nitrosothiols | 🖼🧊📄§ | 2026-04-28 | 2043-10-16 | 0 | 31 |
| 12612384 | Heterocyclic CYP4A inhibitor compounds and compositions thereof | 🖼🧊📄§ | 2026-04-28 | 2042-05-04 | 0 | 31 |
| 12612358 | Resorcinol-based compounds and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2041-12-16 | 0 | 31 |
| 12611378 | Targeted release rifaximin compositions | 🖼🧊📄§ | 2026-04-28 | 2041-06-25 | 0 | 31 |
| 12611458 | Chimeric receptors and methods of use thereof | 🖼🧊📄§ | 2026-04-28 | 2043-04-14 | 0 | 31 |
| 12611444 | IL-36 cytokine expressing oncolytic viruses for treating cancer | 🖼🧊📄§ | 2026-04-28 | 2042-03-17 | 0 | 31 |
| 12612431 | Cyclic compounds for treating cancer | 🖼🧊📄§ | 2026-04-28 | 2042-06-10 | 0 | 31 |
| 12612457 | Humanized antibodies against Nectin-2 and drug conjugates thereof | 🖼🧊📄§ | 2026-04-28 | 2044-08-28 | 0 | 31 |
| 12612597 | Methods for preparing therapeutically active cells using microfluidics | 🖼🧊📄§ | 2026-04-28 | 2041-09-06 | 0 | 31 |
| 12612438 | Bistable type II opsins and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2041-09-19 | 0 | 31 |
| 12611425 | Compositions and methods for treatment and prevention of pathogens | 🖼🧊📄§ | 2026-04-28 | 2043-08-14 | 0 | 31 |
| 12612444 | T cell receptors targeting mutations in RNA splicing factors | 🖼🧊📄§ | 2026-04-28 | 2040-11-25 | 0 | 31 |
| 12612354 | Cyclopentenones derivatives and their use as antibiotics | 🖼🧊📄§ | 2026-04-28 | 2041-12-09 | 0 | 31 |
| 12612365 | Compounds and methods for treating alcohol disorder | 🖼🧊📄§ | 2026-04-28 | 2041-11-30 | 0 | 31 |
| 12612385 | Compounds and methods for targeting pathogenic blood vessels | 🖼🧊📄§ | 2026-04-28 | 2043-11-27 | 0 | 31 |
| 12612369 | Eco-friendly synthesis of a novel nicotinonitrile derivative (MNPN) with antibacterial and anti-inflammatory activities for preventing pressure ulcers in individuals with disabilities | 🖼🧊📄§ | 2026-04-28 | 2045-12-15 | 0 | 31 |
| 12612395 | Rocaglate derivatives and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2044-10-02 | 0 | 31 |
| 12612417 | Deuterated analogues of selenophenochromenes, synthesis thereof, and methods of using same agents | 🖼🧊📄§ | 2026-04-28 | 2040-07-21 | 0 | 31 |
| 12612430 | Peptides | 🖼🧊📄§ | 2026-04-28 | 2040-09-11 | 0 | 31 |
| 12612447 | April and BAFF inhibitory immunomodulatory proteins and methods of use thereof | 🖼🧊📄§ | 2026-04-28 | 2043-03-17 | 0 | 31 |
| 12612446 | CTLA-4 variant immunomodulatory proteins and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2043-01-30 | 0 | 31 |
| 12612451 | Method of treating neuromyelitis optica spectrum disorder (NMOSD) comprising administering an anti-C5 antibody | 🖼🧊📄§ | 2026-04-28 | 2040-12-08 | 0 | 31 |
| 12612449 | HIV-1 antibodies | 🖼🧊📄§ | 2026-04-28 | 2041-06-10 | 0 | 31 |
| 12612456 | CD19 antibodies and methods of using the same | 🖼🧊📄§ | 2026-04-28 | 2040-04-07 | 0 | 31 |
| 12612459 | Methods of identifying agents that block MCD28 cleavage by MMPS | 🖼🧊📄§ | 2026-04-28 | 2040-12-02 | 0 | 31 |